EUVIMEDEUVIMED entdecken
Multizentrische Studie

An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan

Naohisa Yoshida, Yoshikazu Hayashi, Daichi Togo, Shiro Oka, Kazunori Takada, Shusei Fukunaga, Yoshinori Morita, Takemasa Hayashi, Kazuhiro Kozuka, Yosuke Tsuji, Takashi Murakami, Takeshi Yamamura und 37 weitere

Clinical Gastroenterology and Hepatology · 2024-02 · 22 (2) · 271-282.e3

DOI: 10.1016/j.cgh.2023.09.012 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-02. Verfasst von Naohisa Yoshida und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. …. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Colorectal Neoplasms, Atrial Fibrillation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Reported rates of delayed bleeding (DB) after endoscopic resection using direct oral anticoagulants (DOACs) are high and heterogeneous. This large-scale multicenter study analyzed cases of DB after colorectal endoscopic submucosal dissection related to various types of DOACs in Japan (the ABCD-J study) with those associated with warfarin. METHODS: We retrospectively reviewed 1019 lesions in patients treated with DOACs and 459 lesions in patients treated with warfarin among 34,455 endoscopic submucosal dissection cases from 47 Japanese institutions between 2012 and 2021. The DB rate (DBR) with each DOAC was compared with that with warfarin. Risk factors for DB in patients treated with DOACs or warfarin were also investigated. RESULTS: The mean tumor sizes in the DOAC and warfarin groups were 29.6 ± 14.0 and 30.3 ± 16.4 mm, respectively. In the DOAC group, the DBR with dabigatran (18.26%) was significantly higher than that with apixaban (10.08%, P = .029), edoxaban (7.73%, P = .001), and rivaroxaban (7.21%, P < .001). Only rivaroxaban showed a significantly lower DBR than warfarin (11.76%, P = .033). In the multivariate analysis, heparin bridging therapy (odds ratio [OR], 2.18; 95% confidence interval [CI], 1.27-3.73, P = .005), rectal location (2.01, 1.28-3.16, P = .002), and procedure time ≥55 minutes (2.43, 1.49-3.95, P < .001) were significant risk factors for DB in the DOAC group. The DB risk in the DOAC group (OR, (95% CI)) was 2.13 (1.30-3.50) and 4.53 (2.52-8.15) for 1 and 2 significant risk factors, respectively. CONCLUSIONS: Dabigatran was associated with a higher DBR than other DOACs, and only rivaroxaban was associated with a significantly lower DBR than warfarin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionColorectal NeoplasmsAtrial FibrillationHumansWarfarinRivaroxabanDabigatranJapanRetrospective StudiesHemorrhageAnticoagulantsAdministration, Oral

Stichwörter der Autor:innen

AdenomaColorectal LesionsDOACESDPolyps

Substanzen

WarfarinRivaroxabanDabigatranAnticoagulants

Autor:innen und Institutionen

  • Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: naohisa@koto.kpu-m.ac.jp.
  • Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi, Japan.
  • Department of Gastroenterology, Sendai Kousei Hospital, Miyagi, Japan.
  • Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan.
  • Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
  • Department of Gastroenterology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan.

Zitieren

APA

Yoshida, N., Hayashi, Y., Togo, D., Oka, S., Takada, K., Fukunaga, S., Morita, Y., Hayashi, T., Kozuka, K., Tsuji, Y., Murakami, T., Yamamura, T., Komeda, Y., Takeuchi, Y., Shinmura, K., Fukuda, H., Yoshii, S., Ono, S., Katsuki, S., …, & Yamaguchi, N. (2024). An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan. Clinical Gastroenterology and Hepatology, 22(2), 271-282.e3. https://doi.org/10.1016/j.cgh.2023.09.012

Vancouver

Yoshida N, Hayashi Y, Togo D, Oka S, Takada K, Fukunaga S, et al. An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan. Clinical Gastroenterology and Hepatology. 2024;22(2):271-282.e3. doi:10.1016/j.cgh.2023.09.012

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Naohisa and Hayashi, Yoshikazu and Togo, Daichi and Oka, Shiro and Takada, Kazunori and Fukunaga, Shusei and Morita, Yoshinori and Hayashi, Takemasa and Kozuka, Kazuhiro and Tsuji, Yosuke and Murakami, Takashi and Yamamura, Takeshi and Komeda, Yoriaki and Takeuchi, Yoji and Shinmura, Kensuke and Fukuda, Hiroko and Yoshii, Shinji and Ono, Shoko and Katsuki, Shinichi and Kawashima, Kazumasa and Nemoto, Daiki and Yamamoto, Hiroyuki and Saito, Yutaka and Tamai, Naoto and Iwao, Aya and Itoi, Yuki and Tsuji, Shigetsugu and Inagaki, Yoshikazu and Inada, Yutaka and Soga, Koichi and Hasegawa, Daisuke and Murakami, Takaaki and Yoriki, Hiroyuki and Fukumoto, Kohei and Motoyoshi, Takayuki and Nakatani, Yasuki and Sano, Yasushi and Iguchi, Mikitaka and Fujii, Shigehiko and Ban, Hiromitsu and Harada, Keita and Okamoto, Koichi and Nishiyama, Hitoshi and Sasaki, Fumisato and Mizukami, Kazujhiro and Shono, Takashi and Shimoda, Ryo and Miike, Tadashi and Yamaguchi, Naoyuki},
  title = {An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {2},
  pages = {271--282.e3},
  doi = {10.1016/j.cgh.2023.09.012}
}
Kostenlos starten →